After a highly successful decade serving on Microsoft’s board, renowned entrepreneur and venture capitalist Reid Hoffman is hanging up his director’s hat to focus on his artificial intelligence drug discovery startup Manus.

The move marks a significant shift in Hoffman’s priorities, as he looks to dedicate more time and resources to driving Manus’ growth and innovation.

Hoffman’s decision to leave Microsoft comes at a time when the tech giant is undergoing significant changes. The company has been investing heavily in AI research and development, with a focus on enhancing its cloud computing capabilities.

Manus, which was founded by Hoffman in 2019, aims to use AI to accelerate the discovery of new medicines. The startup has already made significant progress in this area, with several high-profile collaborations under its belt.

Hoffman’s departure from Microsoft’s board will undoubtedly be felt, given his significant influence and expertise within the organization. However, his decision to focus on Manus represents a clear vote of confidence in the startup’s potential for growth and impact.

In an interview with Bloomberg, Hoffman stated that he was excited to take on a more hands-on approach at Manus, saying ‘Founder mode’ would allow him to be more agile and responsive to emerging trends and opportunities in AI research.

Manus has already secured significant funding from prominent investors, including Founders Fund and Khosla Ventures. The startup’s progress has been closely watched by industry observers, who see tremendous potential for its AI-powered drug discovery platform.

As Hoffman embarks on this new chapter in his career, it remains to be seen how Manus will evolve and grow. One thing is certain, however: the startup will undoubtedly benefit from Hoffman’s unique blend of entrepreneurial spirit and technical expertise.

The future of Manus looks bright, with a strong team in place and significant resources at its disposal. With Hoffman at the helm, there is little doubt that the startup will continue to push the boundaries of what is possible in AI research and development.